These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 23575677)
21. Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction Breakdown. Zhang P; Feng S; Liu G; Wang H; Zhu H; Ren Q; Bai H; Fu C; Dong C J Biol Chem; 2016 Jan; 291(5):2087-106. PubMed ID: 26504080 [TBL] [Abstract][Full Text] [Related]
22. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin. Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L Elife; 2020 Apr; 9():. PubMed ID: 32312382 [TBL] [Abstract][Full Text] [Related]
23. Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation. Huo Z; Kong Y; Meng M; Cao Z; Zhou Q Vascul Pharmacol; 2019 Jun; 117():7-14. PubMed ID: 29894844 [TBL] [Abstract][Full Text] [Related]
25. Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-α activation and disruption of the p120-vascular endothelial cadherin interaction. Habib A; Karmali V; Polavarapu R; Akahori H; Cheng Q; Pachura K; Kolodgie FD; Finn AV Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2425-31. PubMed ID: 23887639 [TBL] [Abstract][Full Text] [Related]
26. The role of adherens junctions and VE-cadherin in the control of vascular permeability. Dejana E; Orsenigo F; Lampugnani MG J Cell Sci; 2008 Jul; 121(Pt 13):2115-22. PubMed ID: 18565824 [TBL] [Abstract][Full Text] [Related]
27. VE-Cadherin Phosphorylation Regulates Endothelial Fluid Shear Stress Responses through the Polarity Protein LGN. Conway DE; Coon BG; Budatha M; Arsenovic PT; Orsenigo F; Wessel F; Zhang J; Zhuang Z; Dejana E; Vestweber D; Schwartz MA Curr Biol; 2017 Jul; 27(14):2219-2225.e5. PubMed ID: 28712573 [TBL] [Abstract][Full Text] [Related]
28. Losartan protects against myocardial ischemia and reperfusion injury Li Y; Yao Y; Li J; Chen Q; Zhang L; Wang QK FASEB J; 2019 Jul; 33(7):8555-8564. PubMed ID: 30991833 [TBL] [Abstract][Full Text] [Related]
29. VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability. Guo M; Breslin JW; Wu MH; Gottardi CJ; Yuan SY Am J Physiol Cell Physiol; 2008 Apr; 294(4):C977-84. PubMed ID: 18287330 [TBL] [Abstract][Full Text] [Related]
30. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium. Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935 [TBL] [Abstract][Full Text] [Related]
31. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. Xu M; Waters CL; Hu C; Wysolmerski RB; Vincent PA; Minnear FL Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1309-18. PubMed ID: 17670896 [TBL] [Abstract][Full Text] [Related]
32. Dynamic Regulation of Vascular Permeability by Vascular Endothelial Cadherin-Mediated Endothelial Cell-Cell Junctions. Rho SS; Ando K; Fukuhara S J Nippon Med Sch; 2017; 84(4):148-159. PubMed ID: 28978894 [TBL] [Abstract][Full Text] [Related]
33. ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters. Huang RL; Teo Z; Chong HC; Zhu P; Tan MJ; Tan CK; Lam CR; Sng MK; Leong DT; Tan SM; Kersten S; Ding JL; Li HY; Tan NS Blood; 2011 Oct; 118(14):3990-4002. PubMed ID: 21841165 [TBL] [Abstract][Full Text] [Related]
34. Dephosphorylation of Y685-VE-Cadherin Involved in Pulmonary Microvascular Endothelial Barrier Injury Induced by Angiotensin II. Wu Z; Wang Z; Dai F; Liu H; Ren W; Chang J; Li B Mediators Inflamm; 2016; 2016():8696481. PubMed ID: 28119542 [TBL] [Abstract][Full Text] [Related]
35. Differential impairment of adherens-junction expression/phosphorylation after cardioplegia in diabetic versus non-diabetic patients. Feng J; Liu Y; Sabe AA; Sadek AA; Singh AK; Sodha NR; Sellke FW Eur J Cardiothorac Surg; 2016 Mar; 49(3):937-43. PubMed ID: 26069241 [TBL] [Abstract][Full Text] [Related]